Insmed | Ativo Circulante



Current Assets Alterar Data
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
DBV Technologies USD 68.76M 21.2M 2024-09
Dynavax Technologies USD 848.94M 77.3M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
Insmed USD 1.62B 28.18M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Insmed Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.